IV iron for kids with iron deficiency in the ER
Treatments studied
Part of Blood & lymphatic, Hormones & metabolism clinical trials.
This trial tests a type of IV iron called ferric carboxymaltose to treat children with iron deficiency anemia in the emergency department. It aims to find a safe and effective way to quickly raise hemoglobin levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 1 and 18 years old
- Your blood tests must show moderate anemia (hemoglobin between 6 and 10 g/dL) caused by iron deficiency
- You must be stable enough to not need immediate emergency care
- You cannot have active bleeding (periods are okay), cancer, a very low platelet count, or an active infection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies IV ferric derisomaltose to treat iron deficiency anemia in children under 18. It is meant for children whose anemia is from a true iron problem and who either cannot tolerate or do not respond to iron taken by mouth, or have certain kidney-related causes.
This trial studies whether taking iron by mouth can improve iron levels and anemia (low red blood cell counts) in children with chronic kidney disease. It may help reduce fatigue and support normal blood-making, by comparing different approaches for children who meet specific iron test results.
This trial studies whether giving iron through a vein (IV) helps improve anemia caused by heavy uterine bleeding. You may join if you were treated in the emergency department, can go home, and can return for follow-up checks in the next several weeks.
This study compares two ways to give iron to children ages 1 to 5 with iron deficiency anemia. The goal is to see if iron pills or iron given through a vein (IV) works better.
This trial tests ferumoxytol, an intravenous iron medicine, to treat iron deficiency anemia in children who cannot take or did not respond well to iron by mouth. It aims to improve blood iron levels and anemia symptoms safely.
This study tests whether intravenous (IV) iron therapy can help older adults who have heart failure with preserved pumping function and low iron levels. It aims to improve symptoms and quality of life.
Hear when a new Iron Deficiency Anemia Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.